Supplements > Age-Related Macular Degeneration Determining Appropriate Use of Treatments: A Stakeholder Summit
Supplements – Age-Related Macular Degeneration Determining Appropriate Use of Treatments: A Stakeholder Summit
August 18, 2017
In April 2017, in Washington, DC, AJMC® Peer Exchange® hosted a panel of ophthalmology and managed care decision makers and providers to define age-related macular degeneration (AMD) and to provide insight regarding its impact on patients and caregivers. Panelists included Peter Dehnel, MD, medical director of Integrated Health Management at Blue Cross Blue Shield of Minnesota; Jared Nielsen, MD, ophthalmologist specializing in vitreoretinal diseases and surgery at Wolfe Eye Clinic in West Des Moines, Iowa; Charles Wykoff, MD, PhD, director of Clinical Research for Retina Consultants of Houston, and deputy chair for Ophthalmology at Blanton Eye Institute—Houston Methodist Hospital in Houston, Texas; and Gary L. Johnson, MD, MS, MBA, practicing physician and regional medical director in Madison, Wisconsin. The moderator was Peter L. Salgo, MD, a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital in New York.